- Pharming Announces European Medicines Agency (EMA) Validates its Marketing Authorisation Application under Accelerated Assessment for leniolisib
- Pharming submits a Marketing Authorisation Application to the European Medicines Agency for Leniolisib
- Pharming Announces US FDA Acceptance for Priority Review of its New Drug Application for Leniolisib
Pharming Group NV (PHG:DEU) closed at 11.20, -9.68% below its 52-week high of 12.40, set on Dec 01, 2022.
6.45Jun 16 202212.40Dec 01 2022
Markit short selling activity
Data delayed at least 15 minutes, as of Dec 02 2022 15:29 GMT.